EVANSTON, Ill.--(BUSINESS WIRE)--Northfield Laboratories Inc. (Nasdaq: NFLD) announced that Ernest E. “Gene” Moore, M.D., lead investigator of the Company’s pivotal Phase III trial with PolyHeme® for the treatment of urgent, life-threatening blood loss in severely injured patients, reported study findings today at the American College of Surgeons 93rd Annual Clinical Congress in a presentation entitled Post-Injury Resuscitation with Human Polymerized Hemoglobin: The USA Multicenter Trial.
